Modulation of Antibody-Dependent Cellular Cytotoxicity Against Chicken Erythrocyte Targets by Adriamycin and Daunorubicin

References

• Hersh E. M., Gutterman J. U., Mavligit G. M., Mountain C. W., McBride C. M., Burgess M. A. Immunocompetence, immunodeficiency and prognosis in cancer. Ann. N.Y. Acad. Sci. 1976; 276: 386
   PubMed Web of Science ®Google Scholar
• Mikulski S. M., Muggia F. M. Short review: the suppressor mechanisms and their significance in tumor immunology. Cancer Immunol. Immunother. 1978; 4: 139
   Google Scholar
• Blum R. H., Carter S. K. Adriamycin: a new anticancer drug with significant clinical activity. Ann. Intern. Med. 1974; 80: 249
   PubMed Web of Science ®Google Scholar
• Mantovani A., Tagliabue A., Vecchi A., Spreafico F. Effects of adriamycin and daunomycin on spleen cell populations in normal and tumor allografted mice. Eur. J. Cancer 1976; 12: 381
   Google Scholar
• Orsini F. R., Pavelic Z., Mihich E. Increased primary cell-mediated immunity in culture subsequent to adriamycin or daunorubicin treatment of spleen donor mice. Cancer Res. 1977; 37: 1719
   PubMed Web of Science ®Google Scholar
• Mantovani A., Luini W., Peri G., Vecchi A., Spreafico F. Effect of chemotherapeutic agents on natural cell-mediated cytotoxicity in mice. J. Natl. Cancer Inst. 1978; 61: 1255
   PubMed Web of Science ®Google Scholar
• Meriwether W. D., Bachur N. R. Inhibition of DNA and RNA metabolism by daunorubicin and adriamycin in L1210 mouse leukemia. Cancer Res. 1972; 32: 1137
   PubMed Web of Science ®Google Scholar
• Sandberg J. S., Howsden F. L., DiMarco A., Goldin A. Comparison of the antileukemic effect in mice of adriamycin (NSC-123127) with daunomycin (NSC-82151). Cancer Chem. Rep. 1970; 54: 1
   PubMedGoogle Scholar
• Schwartz H. S., Grindey G. B. Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression. Cancer Res. 1973; 33: 1837
   PubMed Web of Science ®Google Scholar
• Yesair D. W., Schwartzbach E., Shuck D., Denine E. P., Asbell M. A. Comparative pharmacokinetics of daunomycin and adriamycin in several animal species. Cancer Res. 1972; 32: 1177
   PubMed Web of Science ®Google Scholar
• Perlmann P., Holm G. Cytotoxic effects of lymphoid cells in vitro. Adv. Immunol. 1969; 11: 117
   PubMedGoogle Scholar
• Pearson G. R. In vitro and in vivo investigations on antibody-dependent cellular cytotoxicity. Curr. Top. Microbiol. Immunol. 1978; 80: 65
   PubMedGoogle Scholar
• Pfeifer R. W. Immunomodulation of antibody-dependent cellular cytotoxicity (ADCC) by adriamycin and daunomycin. Ph. D. Thesis, 1979; 58, 78, 96
   Google Scholar
• The Merck Index - An Encyclopedia of Chemicals and Drugs9th ed., M. Windholz. Merck & Co Inc., Rahway 1976; 456: 371
   Google Scholar
• Kay H. D., Bonnard G. D., West W. H., Herberman R. B. A functional comparison of human Fc-receptor-bearing lymphocytes active in natural cytotoxicity and antibody-dependent cellular cytotoxicity. J. Immunol. 1977; 118: 2058
   PubMed Web of Science ®Google Scholar
• Berger A. E., Amos D. B. A comparison of antibody-dependent cellular cytotoxicity (ADCC) mediated by murine and human lymphoid cell populations. Cell. Immunol. 1977; 33: 277
   PubMedGoogle Scholar
• Perlmann H., Perlmann P., Pape G. R., Hallden G. Purification, fractionation, and assay of antibody-dependent lymphocytic effector (K cells) in human blood. Scand. J. Immunol. Suppl. 1976; 5: 57
   Google Scholar
• Stuart A. E., Habeshaw J. A., Davidson A. E. Handbook of Experimental Immunology, D. M. Weir. Blackwell Scientific Publications, Oxford 1978; 6: 31
   Google Scholar
• Ralph P., Nakoinz I. Environmental and chemical dissociation of antibody-dependent phagocytosis from lysis mediated by macrophages: stimulation of lysis by sulfhydryl-blocking and esterase-inhibiting agents and depression by trypan blue and trypsin. Cell. Immunol. 1980; 50: 94
   PubMedGoogle Scholar
• Sanderson C. J., Thomas J. A. A comparison of the cytotoxic activity of eosinophils and other cells by chromium release and time lapse microcinematography. Immunology 1978; 34: 771
   PubMed Web of Science ®Google Scholar
• Ehrke M. J., Cohen S. A., Mihich E. Selectivity of inhibition by anticancer agents of mouse spleen immune effector functions involved in responses to sheep erythrocytes. Cancer Res. 1978; 38: 521
   PubMedGoogle Scholar
• Hunninghake G. W., Fauci A. S. Divergent effects of cyclophosphamide administration on mononuclear killer cells: quantitative depletion of cell numbers versus qualitative suppression of functional capabilities. J. Immunol. 1976; 117: 337
   PubMedGoogle Scholar
• Canty T. G., Wunderlich J. R., Fletcher F. Qualitative and quantitative studies of cytotoxic immune cells. J. Immunol. 1971; 106: 200
   PubMedGoogle Scholar
• Momparler R. L., Koren M., Siegel S. E., Avila F. Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells. Cancer Res. 1976; 36: 2891
   PubMed Web of Science ®Google Scholar
• Bachur N. R., Gordon S. L., Gee M. V. Anthracycline antibiotic augmentation of microsornal electron transport and free radical formation. Mol. Pharmacol. 1977; 13: 901
   PubMed Web of Science ®Google Scholar
• Bachur N. R., Gordon S. L., Gee M. V. A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Cancer Res. 1978; 38: 1745
   PubMed Web of Science ®Google Scholar
• Orsini F. R., Mihich E. Immunoenhancement of cellular cytotoxicity by adriamycin and daunorubicin. Proc. Am. Assoc. Cancer Res. 1976; 17: 118
   Google Scholar
• Ghaffer A., Calder E. A., Irvine W. J. K cell cytotoxicity against antibody-coated chicken erythrocytes in tumor-bearing mice: its development with progressively growing tumor and the effect of immunization against the tumor. J. Immunol. 1976; 16: 315
   Google Scholar
• Mantovani A., Polentarutti N., Alessandri G., Vecchi A., Guiliani F., Spreafico F. Activation of K cells in mice with transplanted tumors differing in immunogenicity and metastasizing capacity. Br. J. Cancer 1977; 36: 453
   PubMedGoogle Scholar
• Kiessling R., Petrányi G., Kärre K., Jondal M., Tracey D., Wigzell H. Killer cells: a functional conparison between natural, immune T-cell and antibody-dependent in vitro systems. J. Exp. Med. 1976; 143: 772
   PubMed Web of Science ®Google Scholar
• Ojo E., Wigzell H. Natural killer cells may be the only cells in normal mouse lymphoid cell populations endowed with cytolytic ability for antibody-coated tumor target cells. Scand. J. Immunol. 1978; 7: 297
   PubMed Web of Science ®Google Scholar